agilon health, inc. (NYSE:AGL – Get Rating) has received a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $32.71.
A number of brokerages have issued reports on AGL. TheStreet cut agilon health from a “c-” rating to a “d+” rating in a report on Thursday, August 18th. Truist Financial lifted their price objective on agilon health from $30.00 to $33.00 and gave the company a “buy” rating in a report on Thursday, July 14th. Deutsche Bank Aktiengesellschaft cut their price objective on agilon health from $30.00 to $26.00 in a report on Tuesday, May 10th. BTIG Research began coverage on agilon health in a report on Friday, June 24th. They set a “neutral” rating for the company. Finally, Wells Fargo & Company lifted their price objective on agilon health from $23.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, August 8th.
agilon health Stock Down 4.6 %
AGL opened at $21.18 on Friday. agilon health has a fifty-two week low of $14.36 and a fifty-two week high of $38.47. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.65 and a quick ratio of 2.65. The firm’s fifty day moving average price is $23.95 and its two-hundred day moving average price is $21.82. The company has a market capitalization of $8.61 billion, a P/E ratio of -75.64 and a beta of 1.76.
Ad Investing Trends
Copper More Critical than Lithium?
Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper’s importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It’s key to power lines and upgrading the national grid. Analysts say we’re facing a 10-million-ton shortfall if new copper mines are not found.
agilon health (NYSE:AGL – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). agilon health had a negative return on equity of 9.80% and a negative net margin of 4.99%. The business had revenue of $670.13 million for the quarter, compared to analyst estimates of $648.74 million. During the same quarter in the prior year, the firm earned ($0.06) EPS. On average, analysts anticipate that agilon health will post -0.17 EPS for the current year.
Insider Activity at agilon health
In related news, insider Benjamin Kornitzer sold 5,396 shares of agilon health stock in a transaction dated Tuesday, August 23rd. The stock was sold at an average price of $20.49, for a total value of $110,564.04. Following the completion of the sale, the insider now directly owns 10,853 shares in the company, valued at $222,377.97. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Veeral Desai sold 319,071 shares of agilon health stock in a transaction dated Thursday, July 7th. The stock was sold at an average price of $25.00, for a total value of $7,976,775.00. Following the completion of the sale, the insider now directly owns 278,211 shares in the company, valued at $6,955,275. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Benjamin Kornitzer sold 5,396 shares of agilon health stock in a transaction dated Tuesday, August 23rd. The stock was sold at an average price of $20.49, for a total value of $110,564.04. Following the completion of the sale, the insider now owns 10,853 shares of the company’s stock, valued at $222,377.97. The disclosure for this sale can be found here. Insiders sold 11,905,377 shares of company stock valued at $289,963,640 over the last ninety days. 3.30% of the stock is owned by insiders.
Institutional Trading of agilon health
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AGL. Level Financial Advisors Inc. acquired a new position in shares of agilon health during the 2nd quarter worth about $25,000. O Dell Group LLC acquired a new position in shares of agilon health during the 4th quarter worth about $27,000. First Horizon Advisors Inc. grew its position in shares of agilon health by 772.7% during the 1st quarter. First Horizon Advisors Inc. now owns 1,213 shares of the company’s stock worth $31,000 after buying an additional 1,074 shares during the period. Advisor Group Holdings Inc. grew its position in shares of agilon health by 899.4% during the 4th quarter. Advisor Group Holdings Inc. now owns 1,669 shares of the company’s stock worth $47,000 after buying an additional 1,502 shares during the period. Finally, Gleason Group Inc. acquired a new position in shares of agilon health during the 1st quarter worth about $55,000. 96.24% of the stock is currently owned by institutional investors and hedge funds.
agilon health Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider agilon health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and agilon health wasn’t on the list.
While agilon health currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
